HoffmannFounder/President
Founder/President Dellann Elliott Mydland
“The EndBrainCancer Initiative (formerly, The Chris Elliott Fund), was established in May, 2002 by my late husband, Chris Elliott, and I. The reason for this Initiative, the Chris Elliott Fund, and our day-to-day work has always been about IMMEDIATE ACCESS to advanced treatments, studies and clinical trials and the frustration we experienced early on in our brain cancer journey with not being immediately referred to a top brain tumor specialist, neurosurgeon and/or a neuro-oncologist as well as advanced treatments, studies and clinical trials.” [1] (emphasis added)
EBCI recently sent out a questionnaire entitled “Raise your Voice for DCVax-L” with questions such as:
“Would you be willing to join EBCI via Zoom to speak to the FDA to help them understand how VITAL it is for patients with GBM/rGBM to have immediate access to DCVax® – L?”
“Would you be willing to travel to testify to the FDA to help them understand how VITAL it is for patients with GBM/rGBM to have immediate access to DCVax® – L?”
The medical advisory board of EBCI consist of the following DCVax-L P3 JAMA authors:
Dr. Daniella Bota
Dr. Steven Brem
Dr. Timothy Cloughesy
Dr. Samuel Goldlust
Dr. Fabio Iwamoto
Dr. Santosh Kesari
The medical advisory board of EBCI consists of the following doctor seen in Lifespan Cancer Institute’s DCVax-L Press Conference:
Dr. Eric T. Wong
